Skip to main content

Table1 Clinical features of OS patients with or without lung metastasis

From: CCR9 initiates epithelial–mesenchymal transition by activating Wnt/β-catenin pathways to promote osteosarcoma metastasis

Clinical features

OS patients with lung metastasis

OS patients without lung metastasis

P value

(n, %)

(n, %)

All patients

22(100)

65(100)

 

Age at diagnosis, year

 ≤ 18

19(86.4)

54(83.1)

0.7169

 > 18

3(13.6)

11(16.9)

Gender

 Male

10(45.5)

40(61.5)

0.1872

 Female

12(54.5)

25(38.5)

 

Tumor site

 Femur

14(63.7)

26(40.0)

0.2483

 Tibia

3(13.6)

18(27.7)

 

 Fibula

1(4.5)

7(10.8)

 

 Others

4(18.2)

14(21.5)

 

Relapse

 Yes

14(63.6)

24(36.9)

0.0290*

 No

8(36.4)

41(63.1)

 
  1. *Statistically significant